These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 24629851)

  • 1. Single-agent lenalidomide is effective in the treatment of a heavily pretreated and refractory angioimmunoblastic T-cell lymphoma patient.
    Broccoli A; Pellegrini C; Celli M; Argnani L; Agostinelli C; Pileri S; Zinzani PL
    Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):e119-22. PubMed ID: 24629851
    [No Abstract]   [Full Text] [Related]  

  • 2. A four-year spontaneous remission of angioimmunoblastic T-cell lymphoma.
    Cornish N; Maybury B; Otton S
    Br J Haematol; 2018 Jan; 180(2):176. PubMed ID: 29048103
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapy refractory angioimmunoblastic T-cell lymphoma in complete remission with lenalidomide.
    Beckers MM; Huls G
    Eur J Haematol; 2013 Feb; 90(2):162-3. PubMed ID: 23227803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical features and prognostic factors of angioimmunoblastic T cell lymphoma].
    Qin Y; Shi YK; He XH; Yang JL; Zhang CG; Zhou SY; Liu XF; Liu P; Yang S; Zhou LQ; Han XH; Yao JR
    Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):448-51. PubMed ID: 20819488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cerebral angioimmunoblastic T-cell lymphoma.
    Lachenal F; Berger F; Cimarelli S; Formaglio M; Ghesquières H
    J Clin Oncol; 2013 Feb; 31(5):e64-8. PubMed ID: 23295811
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuropathy associated with angioimmunoblastic lymphadenopathy-like T-cell lymphoma.
    Sonobe M; Yasuda H; Okabe H; Terada M; Maeda K; Kawabata T; Kikkawa R
    Intern Med; 1998 Jul; 37(7):631-4. PubMed ID: 9711895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angioimmunoblastic T-cell lymphoma and myelodysplastic syndrome with mutations in
    Tobiasson M; Pandzic T; Cavelier L; Sander B; Wahlin BE
    Leuk Lymphoma; 2019 Dec; 60(13):3316-3319. PubMed ID: 31204875
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment with mogamulizumab of refractory/relapsed angioimmunoblastic T-cell lymphoma following autologous stem cell transplantation.
    Oka S; Ono K; Nohgawa M
    Leuk Lymphoma; 2019 Jun; 60(6):1595-1597. PubMed ID: 30732495
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELA.
    Delfau-Larue MH; de Leval L; Joly B; Plonquet A; Challine D; Parrens M; Delmer A; Salles G; Morschhauser F; Delarue R; Brice P; Bouabdallah R; Casasnovas O; Tilly H; Gaulard P; Haioun C
    Haematologica; 2012 Oct; 97(10):1594-602. PubMed ID: 22371178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Angioimmunoblastic T cell lymphoma complicated with endocapillary proliferative glomerulonephritis].
    Nanno S; Nakamae H; Kuwamura Y; Ishimura E; Sakabe M; Inaba A; Koh S; Yoshimura T; Nishimoto M; Hayashi Y; Terada Y; Nakane T; Koh H; Nakao Y; Ohsawa M; Hino M
    Rinsho Ketsueki; 2013 Jul; 54(7):658-63. PubMed ID: 23912350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of interim FDG PET/CT for predicting outcome of patients with angioimmunoblastic T-cell lymphoma.
    Moon SH; Lee AY; Kim WS; Kim SJ; Cho YS; Choe YS; Kim BT; Lee KH
    Leuk Lymphoma; 2017 Jun; 58(6):1341-1348. PubMed ID: 27718766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual relapse of an angioimmunoblastic T cell lymphoma 11 years after initial manifestation.
    Lohneis P; Jakob C; Hummel M; Jöhrens K; Anagnostopoulos I
    Ann Hematol; 2015 Feb; 94(2):347-9. PubMed ID: 24923452
    [No Abstract]   [Full Text] [Related]  

  • 13. Testicular invading refractory multiple myeloma during bortezomib treatment successfully treated with lenalidomide: a case report.
    Miyao K; Sakemura R; Sakai T; Tsushita N; Kato T; Niimi K; Ono Y; Sawa M
    Ann Hematol; 2014 Mar; 93(3):529-30. PubMed ID: 23820941
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone Marrow Involvement of Epstein-Barr Virus-Positive Large B-Cell Lymphoma in a Patient with Angioimmunoblastic T-Cell Lymphoma.
    Lee T; Park BG; You E; Cho YU; Jang S; Lee SM; Suh C; Park CJ
    Ann Lab Med; 2018 Mar; 38(2):172-175. PubMed ID: 29214764
    [No Abstract]   [Full Text] [Related]  

  • 15. Positive HIV ELISA test, autoimmune hemolytic anemia, and generalized lymphadenopathy: a unifying diagnosis.
    Castillo JJ; Sinclair N; Stachurski D; Jacobsen ED
    Am J Hematol; 2011 Aug; 86(8):690-3. PubMed ID: 21630306
    [No Abstract]   [Full Text] [Related]  

  • 16. T-cell lymphoma manifesting as a uvular mass.
    Lai WS; Wang CH; Shih CP
    Rheumatology (Oxford); 2013 Apr; 52(4):608. PubMed ID: 23264553
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of multiple myeloma: 2009 update.
    Prescrire Int; 2009 Dec; 18(104):263-6. PubMed ID: 20025098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II clinical trial of fludarabine and cyclophosphamide followed by thalidomide for angioimmunoblastic T-cell lymphoma. An NCRI clinical trial. CRUK number C17050/A5320.
    Townsend W; Johnson RJ; Pottinger BT; Counsell N; Smith P; Chadwick H; Evans K; Wickham C; Rudin CE;
    Leuk Lymphoma; 2016 Sep; 57(9):2232-4. PubMed ID: 27001186
    [No Abstract]   [Full Text] [Related]  

  • 19. Angioimmunoblastic T-cell lymphoma: new insights, but the clinical challenge remains.
    Jaffe ES
    Ann Oncol; 1995 Sep; 6(7):631-2. PubMed ID: 8664181
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporine treatment of angioimmunoblastic T-cell lymphoma relapsed after an autologous hematopoietic stem cell transplant.
    Wang X; Zhang D; Wang L; Huang J; Yang Z; Wang J; Chen J; Liu L
    Exp Clin Transplant; 2015 Apr; 13(2):203-5. PubMed ID: 24918480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.